A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

Item
http://www.wikidata.org/entity/Q53965548
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.Helicobacter pylori infection--current treatment practice.Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.Treatment of Helicobacter pylori: future therapeutic and prophylactic perspectives.Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group.High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.Approaches to the Prevention and Treatment of Helicobacter pylori infection.The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
P2860

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

Item
http://www.wikidata.org/entity/Q53965548
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@en
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@nl
type
label
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@en
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@nl
prefLabel
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@en
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
A new 1-week therapy for Helic ...... citrate plus two antibiotics.
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2036.1997.00202.X
P407
P433
P478
P577
P5875
P698
P921